Cargando…
Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study
INTRODUCTION: Anti‐vascular endothelial growth factors (anti‐VEGFs) are considered standard of care therapy for diabetic macular oedema (DME). This study examined treatment patterns and outcomes in patients with DME treated with anti‐VEGF therapy. METHODS: Using anonymized electronic medical record...
Autores principales: | Peto, Tunde, Akerele, Toks, Sagkriotis, Alexandros, Zappacosta, Sofia, Clemens, Andreas, Chakravarthy, Usha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299692/ https://www.ncbi.nlm.nih.gov/pubmed/34796985 http://dx.doi.org/10.1111/dme.14746 |
Ejemplares similares
-
Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years
por: Talks, S. J., et al.
Publicado: (2021) -
PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment
por: Liu, Longhua, et al.
Publicado: (2020) -
APPL1 Counteracts Obesity-Induced Vascular Insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and Endothelin-1 in Mice
por: Wang, Yi, et al.
Publicado: (2011) -
Uncoupling Endothelial Nitric Oxide Synthase Is Ameliorated by Green Tea in Experimental Diabetes by Re-establishing Tetrahydrobiopterin Levels
por: Faria, Aline M., et al.
Publicado: (2012) -
MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic Retinopathy
por: McArthur, Kara, et al.
Publicado: (2011)